Cancer Drug Resistance
| No. | The paper's citation list |
|---|---|
| 1 | ; ; ; doi: |
| 2 | Synergistic cytotoxicity of the CDK4 inhibitor Fascaplysin in combination with EGFR inhibitor Afatinib against Non-small Cell Lung Cancer. 2022;40:215 doi: 10.1007/s10637-021-01181-8 |
| 3 | Vascular normalization and immunotherapy: Spawning a virtuous cycle. 2022;12: doi: 10.3389/fonc.2022.1002957 |
